ABSTRACT
DERMATOPHYTOSIS Cutaneous fungal infections are a worldwide health concern. While the majority of dermatophyte infections are benign when affecting otherwise healthy individuals, infections in elderly or immunocompromised patients may be accompanied by significant morbidity or mortality. Some forms of dermatomycosis are increasing in incidence, whereas others remain rare (1). Although newer oral antifungal agents for the treatment of invasive and superficial infections have significantly improved the efficacy of treatment for many fungal infections, side effects, drug interactions, and resistant organisms have created a challenge to find safer and more effective treatments. This chapter blends current clinical knowledge of superficial and cutaneous fungal infections with recent advances in management.
